Staar Surgical Brings Back Former CEO Bailey as Commercial Chief

Dow Jones
昨天
 
 

Staar Surgical is bringing back a former chief executive to run its commercial operations.

David Bailey is expected to rejoin the company as chief commercial officer, the maker of implantable lenses said Tuesday.

Bailey served as president and chief executive of Staar from 2001 to 2008. He was president of international operations for about three years after that.

During his tenure, he launched the commercialization of implantable collamer lenses in Asia. He also drove the development of the central port, which eliminates the need for a peripheral iridotomy laser procedure.

Bailey also raised more than $60 million and secured Food and Drug Administration approval for implantable lenses in 2005.

After leaving Staar, Bailey served as chief executive of Sensimed, a Swiss glaucoma diagnostics company. He also led Medicem's U.S. women's health business.

 
 

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10